AIA Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,832
Closed -$318K 306
2023
Q3
$318K Buy
2,832
+81
+3% +$10.3K 0.02% 251
2023
Q2
$401K Buy
+2,751
New +$374K 0.02% 268
2022
Q3
Sell
-1,408
Closed -$148K 456
2022
Q2
$148K Hold
1,408
0.01% 409
2022
Q1
$180K Buy
1,408
+602
+75% +$72.6K 0.01% 387
2021
Q4
$99K Buy
+806
New +$105K ﹤0.01% 418

Other funds holding ZBH

AIA Group's ZBH Position: Q4 2023 in Review

AIA Group sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 2,832 shares — an estimated $318K sold.

AIA Group first reported a position in ZBH in Q4 2021 and held it in 5 quarters. The position peaked at $401K in Q2 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • AIA Group reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • AIA Group sold 2,832 Zimmer Biomet shares in Q4 2023, an estimated $318K.
  • AIA Group first reported a position in Zimmer Biomet in Q4 2021 and held it in 5 quarters.
  • AIA Group's Zimmer Biomet position peaked at $401K in Q2 2023.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on AIA Group's 13F filing for Q4 2023, filed 31 Jan 2024.